Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Whitehawk Therapeutics (WHWK) Asset Utilization Ratio (2018 - 2025)

Whitehawk Therapeutics (WHWK) has disclosed Asset Utilization Ratio for 8 consecutive years, with 0.08 as the latest value for Q3 2025.

  • On a quarterly basis, Asset Utilization Ratio fell 69.1% to 0.08 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.08, a 69.1% decrease, with the full-year FY2024 number at 0.26, up 66.64% from a year prior.
  • Asset Utilization Ratio was 0.08 for Q3 2025 at Whitehawk Therapeutics, down from 0.1 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.38 in Q2 2021 to a low of 0.0 in Q3 2021.
  • A 5-year average of 0.17 and a median of 0.15 in 2022 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: plummeted 100.33% in 2021, then surged 14423.77% in 2022.
  • Whitehawk Therapeutics' Asset Utilization Ratio stood at 0.09 in 2021, then fell by 5.43% to 0.08 in 2022, then soared by 122.56% to 0.18 in 2023, then surged by 86.06% to 0.33 in 2024, then crashed by 75.17% to 0.08 in 2025.
  • Per Business Quant, the three most recent readings for WHWK's Asset Utilization Ratio are 0.08 (Q3 2025), 0.1 (Q2 2025), and 0.18 (Q1 2025).